2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Mycophenolate: new trials by email Literature Review of Mycophenolate trials Research Report on Mycophenolate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging - Leukemia, Lymphoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 20 | 2013-01-01 | 2020-05-05 |
| Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis mycophenolate mofetil, placebo - Systemic Lupus Erythematosus, Arthritis | Phase 1 / Phase 2 | Completed | Oklahoma Medical Research Foundation | 27 | 2006-11-01 | 2020-10-09 |
Arthritis (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lupus Erythematosus, Systemic (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1)
M.D. Anderson Cancer Center (1) · Oklahoma Medical Research Foundation (1)
United States (2)
Issa F. Khouri, MD,BS (1) · Joan T. Merrill, M.D. (1) · Robert Clancy, PhD (1)